cholestyramine resin has been researched along with Hepatic Porphyria in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KE; Ávila, MA; Deybach, JC; Fontanellas, A | 1 |
1 review(s) available for cholestyramine resin and Hepatic Porphyria
| Article | Year |
|---|---|
Current and innovative emerging therapies for porphyrias with hepatic involvement.
Topics: 5-Aminolevulinate Synthetase; Acetylgalactosamine; alpha-MSH; Bone Marrow Transplantation; Cholestyramine Resin; Genetic Therapy; Heme; Humans; Liver; Liver Transplantation; Porphyrias, Hepatic; Porphyrins; Pyrrolidines; Receptor, Melanocortin, Type 1 | 2019 |